MYGN vs NEOG
Myriad Genetics Inc. and Neogen Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | MYGN | NEOG |
|---|---|---|
| Revenue | $824.5M | $870.4M |
| Net income | $-365.9M | $-7.9M |
| Gross margin | 69.9% | 46.9% |
| Net margin | −44.4% | −0.9% |
| Return on equity | −68.5% | −0.4% |
| Diluted EPS | −$3.95 | −$0.04 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $31.9M |
| Equity | $368.0M | $2.1B |
| Net debt / equity | −0.08× | 0.29× |
| Current ratio | 2.49× | 3.82× |
| Revenue CAGR 5y | 8.2% | 13.2% |
| Profit CAGR 5y | · | · |
MYGN and NEOG book revenue within 15% of each other, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | MYGN | NEOG |
|---|---|---|
| FY2025 | $824.5M | $870.4M |
| FY2024 | $837.6M | $894.7M |
| FY2023 | $753.2M | $924.2M |
| FY2022 | $678.4M | $822.4M |
| FY2021 | $690.6M | $527.2M |
| FY2020 | $557.1M | $468.5M |
| FY2019 | $638.6M | $418.2M |
| FY2018 | $851.1M | $414.2M |
| FY2017 | $743.7M | $397.9M |
| FY2016 | $728.7M | $358.3M |
Bottom line
| Fiscal year | MYGN | NEOG |
|---|---|---|
| FY2025 | $-365.9M | $-7.9M |
| FY2024 | $-127.3M | $-1.1B |
| FY2023 | $-263.3M | $-9.4M |
| FY2022 | $-112.0M | $-22.9M |
| FY2021 | $-27.2M | $48.3M |
| FY2020 | $-223.6M | $60.9M |
| FY2019 | $-199.5M | $59.5M |
| FY2018 | $4.6M | $60.2M |
| FY2017 | $133.3M | $63.1M |
| FY2016 | $17.4M | $43.8M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$45,900,000 | NEOG |
| FY2024 | −$57,100,000 | NEOG |
| FY2023 | −$171,000,000 | NEOG |
| FY2022 | −$144,047,000 | NEOG |
| FY2021 | +$163,441,000 | MYGN |
| FY2020 | +$88,641,000 | MYGN |
| FY2019 | +$220,430,000 | MYGN |
| FY2018 | +$436,914,000 | MYGN |
| FY2017 | +$345,770,000 | MYGN |
| FY2016 | +$370,423,000 | MYGN |
| FY2015 | +$419,225,000 | MYGN |
| FY2014 | +$439,426,000 | MYGN |
| FY2013 | +$530,795,000 | MYGN |
| FY2012 | +$405,672,000 | MYGN |
| FY2011 | +$311,959,000 | MYGN |
| FY2010 | +$229,401,000 | MYGN |
| FY2009 | +$222,139,000 | MYGN |
The higher-revenue side has changed between MYGN and NEOG over this period. The gap has narrowed since the earliest year compared.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −43.5 pp | NEOG |
| FY2024 | +106.9 pp | MYGN |
| FY2023 | −33.9 pp | NEOG |
| FY2022 | −13.7 pp | NEOG |
| FY2021 | −13.1 pp | NEOG |
| FY2020 | −53.2 pp | NEOG |
| FY2019 | −45.5 pp | NEOG |
| FY2018 | −14.0 pp | NEOG |
| FY2017 | +2.0 pp | MYGN |
| FY2016 | −9.9 pp | NEOG |
| FY2015 | +4.5 pp | MYGN |
| FY2014 | −0.8 pp | NEOG |
| FY2013 | +11.3 pp | MYGN |
| FY2012 | +11.0 pp | MYGN |
| FY2011 | +10.4 pp | MYGN |
| FY2010 | +11.8 pp | MYGN |
| FY2009 | +29.5 pp | MYGN |
The higher net margin has changed hands between MYGN and NEOG over this period.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NEOG's net margin has been more volatile than MYGN's over the 17 comparable fiscal years — 31.6 percentage points of standard deviation against 25.4.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MYGN and NEOG over these 17 fiscal years — MYGN led in 8 and NEOG in 9.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
MYGN's return on equity has been more volatile than NEOG's over the 17 comparable fiscal years — 24.8 percentage points of standard deviation against 12.6.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between MYGN and NEOG over these 17 fiscal years — MYGN led in 9 and NEOG in 8.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.